Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Polycystic Ovary Syndrome 1Oligomenorrhea 1Motor Activity 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1Leukemia 1Insulin Resistance 1Hyperandrogenism 1Hodgkin Disease 1Hirsutism 1Fatigue 1Diabetes Mellitus, Type 1 1Depression 1Congenital Abnormalities 1Breast Neoplasms 1

Interventions

Metformin 152Clomiphene 52Letrozole 41Inositol 35Folic Acid 18Progesterone 17Exercise 17Ethinyl Estradiol 13Estradiol 13Chorionic Gonadotropin 13Caloric Restriction 13drospirenone and ethinyl estradiol combination 12Contraceptives, Oral 12cetrorelix 11Pioglitazone 10High-Intensity Interval Training 10Cholecalciferol 10Triptorelin Pamoate 9Tablets 9Spironolactone 9Menotropins 8Diet 8Vitamin D 7Thioctic Acid 7Surveys and Questionnaires 7Liraglutide 7Gonadotropins 7Acupuncture Therapy 7follitropin alfa 6drospirenone 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Polycystic Ovary Syndrome × Body Composition × Clear all
NCT04979377 2025-03-17

Prevalence of Hyperandrogenism in Type 1 Diabetes

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

Completed
150 enrolled

Diabetes Mellitus, Type 1, Hirsutism, Insulin Resistance, Oligomenorrhea, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡